Pentosan Polysulfate molecular structure
Pentosan Polysulfate molecular structure
Approved
💪Tissue Repair

Pentosan Polysulfate

Also known as: PPS, Cartrophen

MW

6000.00 Da

CAS

37319-17-8

Routes

2 routes

Pentosan polysulfate sodium (PPS) is a semi-synthetic sulfated polysaccharide derived from beech wood hemicellulose, structurally similar to heparin and glycosaminoglycans. While not a peptide, it is included in peptide databases due to its use alongside peptides in regenerative medicine. FDA-approved as Elmiron (1996) for interstitial cystitis/bladder pain syndrome, PPS has glycosaminoglycan-like properties that restore the bladder's protective mucous lining (GAG layer). PPS has also been investigated for osteoarthritis (approved in Australia as Pentosan Equine for veterinary use), blood clotting disorders, and prion diseases. Recent concern about maculopathy (retinal damage) with long-term use has impacted its clinical use for interstitial cystitis.

Research Use OnlyFor educational and research purposes only

Research Applications

Interstitial Cystitis (Approved)

FDA-approved as Elmiron. Reduces bladder pain and urinary urgency/frequency in IC/BPS patients.

Osteoarthritis

TGA-approved in Australia for veterinary osteoarthritis. Human trials show chondroprotective effects.

Prion Diseases

Research suggests PPS may inhibit prion protein aggregation.

Mechanism of Action

PPS coats the damaged urothelium, restoring the protective GAG (glycosaminoglycan) layer that prevents irritating urinary solutes from penetrating to underlying nerve fibers. It also has anti-inflammatory (inhibits mast cell histamine release), anticoagulant (weak heparin-like activity), and fibrinolytic properties. In joints, PPS stimulates hyaluronic acid synthesis and inhibits degradative enzymes (MMPs, aggrecanases).

Biological Pathways

GAG layer restoration in bladder. Mast cell stabilization. MMP inhibition in cartilage. Hyaluronic acid synthesis stimulation. Weak antithrombin III-mediated anticoagulation.

Dosage Information

Typical dosage ranges for research applications. Always verify with current literature.
Typical Dose
300,000 mcg
Dose Range
100,000 - 300,000 mcg
Frequency
100 mg 3x daily, 1 hour before meals
Dosage Calculator
Calculate precise peptide dosages based on your reconstitution parameters
Dosage calculation parameters
Vial size in milligrams
Reconstitution volume in milliliters
Body weight input
Recommended dose per kg
mcg/kg
Desired dose input
mcg

Calculation Results

Concentration
2.5 mg/ml
Dose Volume
0.1 ml0.100 ml
Insulin Syringe
10 units
Doses per Vial
2020 doses @ 250 mcg

Syringe Fill Level (100u syringe)

05010010.0uunits
0u10.0 / 100 units (10%)100u

Protocols

No protocols featuring this peptide yet.

Browse All Protocols

Stability & Storage

Oral capsules (Elmiron 100 mg) store at room temperature. Injectable form (veterinary) at room temperature. Stable compound with 3+ year shelf life.

Side Effects & Precautions

GI effects (nausea, diarrhea, 4%), alopecia (4%), headache. Maculopathy (pigmentary retinal changes) identified with long-term use (>3 years) — requires ophthalmological monitoring. Mild anticoagulant effect — use caution with blood thinners.

Research Use Only. This information is for educational and research purposes only. Not intended for medical advice or self-medication.

Regulatory Status

Approved

FDA-approved as Elmiron (1996) for interstitial cystitis. Box warning about maculopathy risk added. Available by prescription only. Not WADA-prohibited.

Research Studies

Pentosan Polysulfate for Interstitial Cystitis

Hanno PM.

Urology
1997
View Source

PPS-Associated Maculopathy

Pearce WA, Chen R, Jain N.

Ophthalmology
2018
View Source
Dosage Calculator
Calculate reconstitution volumes and injection amounts for Pentosan Polysulfate.
Explore More
Explore more peptides in the Tissue Repair category and related research.